BIOMAT Database Logo BIOMAT Database Logo

Successful use of subcutaneous recombinant human erythropoietin before cholecystectomy in an anemic patient with religious objections to transfusion therapy. 1991

J L Fletcher, and J C Perez, and D H Jones
Department of Family Medicine, Medical College of Georgia, Augusta.

Use of recombinant human erythropoietin has been advocated for therapy in anemic patients with end-stage renal disease and to enhance the harvesting of autologous red blood cells from healthy patients scheduled for elective orthopedic surgery. The authors report the case of a diabetic patient with moderate chronic renal failure and cholelithiasis but whose religious beliefs forbade the use of transfusion therapy. She underwent successful cholecystectomy only after treatment with recombinant human erythropoietin.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D012068 Religion and Medicine The interrelationship of medicine and religion. Religiosity Coping,Spiritual Coping,Medicine and Religion,Coping, Religiosity,Coping, Spiritual,Religiosity Copings
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D002763 Cholecystectomy Surgical removal of the GALLBLADDER. Cholecystectomies
D002764 Cholecystitis Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases. Empyema, Gallbladder,Gallbladder Inflammation,Empyema, Gall Bladder,Gall Bladder Empyema,Gallbladder Empyema,Inflammation, Gallbladder
D002769 Cholelithiasis Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS). Gallstone Disease,Cholelithiases,Gallstone Diseases
D002835 Christianity The religion stemming from the life, teachings, and death of Jesus Christ: the religion that believes in God as the Father Almighty who works redemptively through the Holy Spirit for men's salvation and that affirms Jesus Christ as Lord and Savior who proclaimed to man the gospel of salvation. (From Webster, 3d ed) Stigmata,Christian Ethics,Christian Ethic,Ethic, Christian,Ethics, Christian
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.

Related Publications

J L Fletcher, and J C Perez, and D H Jones
Recombinant human erythropoietin in mildly anemic women before total hysterectomy.
January 2003, Clinical and experimental obstetrics & gynecology,
J L Fletcher, and J C Perez, and D H Jones
Successful recombinant erythropoietin therapy for a developing anemic newborn with hereditary spherocytosis.
April 2006, Pediatrics international : official journal of the Japan Pediatric Society,
J L Fletcher, and J C Perez, and D H Jones
[Hyporesponsiveness to recombinant human erythropoietin therapy in anemic patients on hemodialysis].
June 2004, Nihon rinsho. Japanese journal of clinical medicine,
J L Fletcher, and J C Perez, and D H Jones
Therapeutic use of continuous subcutaneous infusion of recombinant human erythropoietin in malnourished predialysis anemic patients with diabetic nephropathy.
October 1998, European journal of endocrinology,
J L Fletcher, and J C Perez, and D H Jones
Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
February 1989, Clinical nephrology,
J L Fletcher, and J C Perez, and D H Jones
[Autologous blood transfusion with erythropoietin in heart surgery in an anemic patient].
February 1992, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
J L Fletcher, and J C Perez, and D H Jones
Patient selection and predicting response to recombinant human erythropoietin in anemic cancer patients.
January 1996, Seminars in hematology,
J L Fletcher, and J C Perez, and D H Jones
Successful use of recombinant human erythropoietin in pregnancy.
January 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J L Fletcher, and J C Perez, and D H Jones
Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient.
August 2001, Annals of hematology,
J L Fletcher, and J C Perez, and D H Jones
Adverse events of subcutaneous recombinant human erythropoietin therapy.
January 1992, Contributions to nephrology,
Copied contents to your clipboard!